EHR Nudges for Overmedication
(HRPP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on helping doctors reduce high-risk medication use, so it's best to discuss your specific situation with the trial team.
What data supports the effectiveness of this treatment?
Is the EHR nudge system safe for humans?
How does the EHR nudge treatment for overmedication differ from other treatments?
The EHR nudge treatment is unique because it uses behavioral economics principles integrated into electronic health records to subtly guide doctors towards better prescribing practices, reducing overmedication without adding extra mental workload. This approach is novel compared to traditional methods, as it focuses on changing clinician behavior through decision support systems rather than directly altering patient medication regimens.12468
What is the purpose of this trial?
High-risk polypharmacy is common among older adults in the United States, is particularly dangerous for individuals with dementia or cognitive impairment, and is associated with harms such as adverse drug reactions, falls, and higher costs of care. This project aims to test in a pragmatic clinic-randomized controlled trial two electronic health record-based behavioral economic nudges to help clinicians reduce high-risk polypharmacy among their older adult patients and in the subgroup with dementia or cognitive impairment.The main questions this trial aims to answer are:Aim 1: To evaluate the effects of an EHR-based commitment nudge, a justification nudge, and the combination of both nudges on a composite measure of high-risk polypharmacy via a pragmatic randomized controlled trial. The investigators will use cluster randomization in which primary care clinics are randomized to receive 0, 1, or 2 nudges using a factorial design. The nudges will run for 18 months, followed by 12 months of observation to assess persistence of effects.Aim 2: To qualitatively and quantitatively assess clinician experiences with the EHR-based nudges, including their acceptability and effects on workflow. At the conclusion of the intervention period, the investigators will perform semi-structured interviews and field a clinician survey.
Eligibility Criteria
This trial is for older adults at high risk of polypharmacy, especially those with dementia or cognitive impairment. It's being conducted in Northwestern Medicine or UPMC primary care clinics that specialize in Internal Medicine, Family Medicine, General Practice, or Geriatrics.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of EHR-based commitment and justification nudges to reduce high-risk polypharmacy
Observation
Observation period to assess persistence of effects from the intervention
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Clinical decision support (CDS)-Commitment nudge
- Clinical decision support (CDS)-Justification nudge
- Clinician education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
University of Pittsburgh Medical Center
Collaborator
University of Southern California
Collaborator
University of California, Los Angeles
Collaborator